Financials
- Market Capitalization 21.19 M
- Employee 10
- Founded 2006
- CEO N/A
- Website www.cocrystalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000V27360
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.26
ratio cours/chiffre d'affaires
204.68
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4546 | LGVN Longeveron Inc. - Class A Common stock | 6.72 USD | -1.18% | +690.59% | +1020.00% | +1076.26% | 21.42 M USD | ||
| 4548 | ENLV Enlivex Ltd. - Ordinary Shares | 1.35 USD | -8.78% | -8.78% | -40.00% | +29.81% | 21.36 M USD | ||
| 4557 | AKTX Akari Therapeutics Plc - American Depositary Shares | 10.70 USD | +18.76% | +33.75% | +33.75% | +1289.61% | 20.83 M USD | ||
| 4563 | NEUP Neuphoria Therapeutics Inc. - Common Stock | 3.76 USD | -0.27% | -3.59% | -1.05% | -66.81% | 20.32 M USD |